Study of Tumor Treating Fields With Hypofractionated Chemoradiotherapy in Newly Diagnosed Glioblastoma

NCT04474353 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Glioblastoma
Newly Diagnosed Glioblastoma

Interventions

DEVICE: Optune
DRUG: Gadolinium
DRUG: Temozolomide
RADIATION: Stereotactic radiosurgery (SRS)

Sponsor

Stanford University

Collaborators

[object Object]